1. Barnabas RV, Garnett GP (2004) The potential public health impact of vaccines against human papillomavirus. European Consortium for Cervical Cancer Education, (in press)
2. Beral V, Hermon C, Munoz N, Devesa SS (1994) Cervical cancer. Cancer Surv 19–20:265–285
3. Bodner K, Bodner-Adler B, Wierrani F, Kimberger O, Denk C, Grunberger W (2002) Is therapeutic conization sufficient to eliminate a high-risk HPV infection of the uterine cervix? A clinicopathological analysis. Anticancer Res 22:3733–3736
4. Cuzick J, Szarewski A, Cubie H, Hulman G, Kitchener H, Luesley D, McGoogan E, Menon U, Terry G, Edwards R, Brooks C, Desai M, Gie C, Ho L, Jacobs I, Pickles C, Sasieni P (2003) Management of women who test positive for high-risk types of human papillomavirus: the HART study. Lancet 362:1871–1876
5. de Brux J, Orth G, Croissant O, Cochard B, Ionesco M (1983) Condylomatous lesions of the uterine cervix: their course in 2466 patients. Bull Cancer 70:410–422